WVE

Wave Life Sciences Ltd. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-02-26

Figures on this page computed 2026-11-08 12:40 UTC

Last close

3.62USD

Market data, 2026-11-04

Except where said otherwise: 10-K for 2025, filed 2026-02-26

n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0001193125-26-073472
Reported in
USD
- computed
- 10-K for 2025, filed 2026-02-26
The filing itself
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001193125-26-073472
Reported in
USD
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
- 10-Q for 2025, filed 2026-10-27
- 10-K for 2025, filed 2026-02-26
- 10-Q for 2025, filed 2026-10-27
The filing itself
-478.3%Net margin
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001193125-26-073472
Reported in
USD
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
The filing itself
-440.5%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001193125-26-073472
Reported in
USD
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
The filing itself
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0001193125-26-073472
Reported in
USD
- 10-K for 2025, filed 2026-02-26
- 10-Q for 2025, filed 2026-10-27
The filing itself
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Margins is the furthest below its sector's middle: 0.07 against 0.23 on the market's range.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

Five bars, one line

lens 7 of 9

1.17x

1.58x

1.77x

n/a

0.24x

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Filed2025

Market data2026-11-04

Each against its own average

4 of 5 read

Except where said otherwise: 10-K for 2025, filed 2026-02-26

Sales1.17x
Its own average over 10 years, 36.5M.
Profit1.58x
Its own average over 10 years, -129.1M.
Free cash flow1.77x
Its own average over 10 years, -106.2M.
Debtn/a
Its own average over 0 years.
Price0.24x
Its own average over 11 years, 15. Market data, 2026-11-04

Free cash flow is furthest from its own average, at 1.77 times.

Sales is 1.17 times its own 10-year average; Profit is 1.58 times its own 10-year average; Free cash flow is 1.77 times its own 10-year average; Price is 0.24 times its own 11-year average.

Every figure in this lens

Except where said otherwise: 10-K for 2025, filed 2026-02-26

Sales against its own 10-year average1.17
Source
filed
Statement
income
Fiscal year
2025
Accession
0001193125-26-073472
Reported in
USD
The filing itself
Profit against its own 10-year average1.58
Source
filed
Statement
income
Fiscal year
2025
Accession
0001193125-26-073472
Reported in
USD
The filing itself
Free cash flow against its own 10-year average1.77
Source
filed
Statement
income
Fiscal year
2025
Accession
0001193125-26-073472
Reported in
USD
The filing itself
Debt against its own 0-year averagen/a
Not held.
Source
filed
Statement
income
Fiscal year
2025
Accession
0001193125-26-073472
Reported in
USD
The filing itself
Price against its own 11-year average0.24Market data, 2026-11-04
Source
market
Taken on
2026-11-04
Reported in
USD